Dexmal Secures ~¥1B (~$140M) Across Two Rounds Led by Alibaba and NIO Capital
Want to read in a language you're more familiar with?
Dexmal raises “hundreds of millions of RMB” in A+ funding led by Alibaba; A + A+ total near ¥1B (~$140M) to accelerate embodied-AI robots.
On Nov. 14, 2025, Embodied-AI startup Dexmal announced an A+ round of “hundreds of millions of RMB”, with Alibaba as lead investor. Together with its earlier Series A—led by NIO Capital with Hongtai Fund, Lenovo Capital, Xichuang Investment, Zhengjing Fund and others participating, plus follow-ons from Legend Capital, Qiming Venture Partners and Jiukun Ventures—the company said the two rounds total close to ¥1 billion (about $140 million). Proceeds will go to robotics software/hardware R&D and commercialization.
Founded in March 2025, Dexmal focuses on end-to-end embodied intelligence. Its in-house MMLA large model fuses multi-sensor inputs with LLM, VLM, VLA and world-model capabilities to generalize across scenarios, tasks and robot configurations, according to the company. Dexmal has also open-sourced a PyTorch-based VLA toolbox, “Dexbotic,” and introduced an open-source robot hardware platform, DOS-W1, to lower deployment and maintenance barriers.
Dexmal frames the fresh capital as fuel for moving from research to scaled application—standardizing data collection, training and on-device inference workflows and accelerating real-world pilots.
